Fundraising Fox

PD Theranostics, Inc.

New York, US · Founded 2019 · Delaware corporation · 1 known investors

Founders & leadership

MD
Matthew DuffyPresident, Treasurer, Secretary
PG
Patrick GallagherChief Executive Officer
JA
James AhernNamed on SEC filing
ME
Matthew EitnerNamed on SEC filing

Investors · 1

Reported raises · per SEC filings

Form D private placements

$508.2K disclosed across 2 rounds · 2022

$150KraisedDec 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew EitnerDirector
  • Patrick GallagherExecutive Officer, Director
  • James AhernDirector
  • Matthew DuffyExecutive Officer, Director
Offering amount
$1M
Amount sold
$150K
Sales commissions
$15K
Proceeds to insiders
$60K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$358.2KraisedJul 2022 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Matthew DuffyExecutive Officer
  • James AhernDirector
  • Patrick GallagherExecutive Officer, Director
  • Matthew EitnerDirector
Offering amount
$5.9M
Amount sold
$358.2K
Sales commissions
$43K
Proceeds to insiders
$60K
Placement agents
Laidlaw & Company (UK) Ltd.
First sale
Jul 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

Who are PD Theranostics, Inc.'s investors?
PD Theranostics, Inc.'s investors include Lucius Partners.
How much funding has PD Theranostics, Inc. raised?
PD Theranostics, Inc. has disclosed $508.2K raised across 2 rounds.
Where is PD Theranostics, Inc. headquartered?
PD Theranostics, Inc. is headquartered in New York, US.